Inhibitory effect of desoxyrhaponticin and rhaponticin, two natural stilbene glycosides from the Tibetan nutritional food Rheum tanguticum Maxim. ex Balf., on fatty acid synthase and human breast cancer cells

Food and Function

Volumn 5, Issue 2, 2014, Pages 251-256

  Li, Ping ^a   Tian, Weixi ^a   Wang, Xiaoyan ^b   Ma, Xiaofeng ^a  

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^b NORTHWEST INSTITUTE OF PLATEAU BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSYNTHESIS PATHWAYS; FATTY ACID SYNTHASE; HUMAN BREAST CANCER; HUMAN BREAST CANCER CELLS; HUMAN CANCER CELLS; INHIBITORY EFFECT; POTENTIAL TARGETS; THERAPEUTIC AGENTS;

BIOCHEMISTRY; CELL DEATH; DISEASES; PLANTS (BOTANY); SUGARS;

FATTY ACIDS;

DESOXYRHAPONTICIN; ENZYME INHIBITOR; FATTY ACID; FATTY ACID SYNTHASE; PLANT EXTRACT; RHAPONTIN; STILBENE DERIVATIVE;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; BREAST TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; CHINA; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FEMALE; HUMAN; METABOLISM; PATHOPHYSIOLOGY; RHEUM; TUMOR CELL LINE;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; ENZYME INHIBITORS; FATTY ACID SYNTHASES; FATTY ACIDS; FEMALE; HUMANS; PLANT EXTRACTS; RHEUM; STILBENES; TIBET;

EID: 84893247745     PISSN: 20426496     EISSN: 2042650X     Source Type: Journal    
DOI: 10.1039/c3fo60484e     Document Type: Article

References (40)

1. M. Yang D. Zhang J. Zheng J. Liu Pollen morphology and its systematic and ecological significance in Rheum (Polygonaceae) from China Nord. J. Bot. 2001 21 411 418
2. X. M. Wang Y. Ren Rheum tanguticum, an endangered medicinal plant endemic to China J. Med. Plants Res. 2009 3 1195 1203
3. X. Wang R. Yang S. Feng X. Hou Y. Zhang Y. Li Y. Ren Genetic variation in Rheum palmatum and Rheum tanguticum (Polygonaceae), two medicinally and endemic species in China using ISSR markers PLoS One 2012 7 e51667
4. G. Nonaka M. Minami I. Nishioka Studies on rhubarb (Rhei rhizoma). III. Stilbene glycosides Chem. Pharm. Bull. 1977 25 2300 2305
5. W. Jin R. L. Ge Z. Q. Huang Q. J. Wei T. Y. Bao P. F. Tu Chemical constituents of Rheum tanguticum Maxim. ex Balf. J. Chin. Pharm. Sci. 2006 15 206 210
6. Z. Q. Chen Z. J. Li Z. L. Fu C. L. Wang Study on determination of rhaponticin in Rheum hotaoense by HPLC J. Clin. Lab. Anal. 2009 28 101 103
7. J. J. Wang Z. Q. Chen S. X. Wang Measurement of desoxyrhaponticin in Rheum franzenbachii by high performance liquid chromatography Acta Agric. Jiangxi 2008 20 59 60
8. H. Matsuda T. Morikawa I. Toguchida J. Y. Park S. Harima M. Yoshikawa Antioxidant constituents from rhubarb: structural requirements of stilbenes for the activity and structures of two new anthraquinone glucosides Bioorg. Med. Chem. 2001 9 41 50
9. H. Matsuda N. Tomohiro K. Hiraba S. Harima S. Ko K. Matsuo M. Yoshikawa M. Kubo Study on anti-oketsu activity of rhubarb II. Anti-allergic effects of stilbene components from rheiundulati rhizoma (dried rhizome of Rheum undulatum cultivated in Korea) Biol. Pharm. Bull. 2001 24 264 267
10. H. Matsuda S. Tewtrakul T. Morikawaa M. Yoshikawa Anti-allergic activity of stilbenes from Korean rhubarb (Rheum undulatum L.): structure requirements for inhibition of antigen-induced degranulation and their effects on the release of TNF-a and IL-4 in RBL-2H3 cells Bioorg. Med. Chem. 2004 12 4871 4876
11. L. S. Lv X. H. Gu J. Tang C. T. Ho Antioxidant activity of stilbene glycoside from Polygonum multiflorum Thunb in vivo Food Chem. 2007 104 1678 1681
12. I. H. Son I. M. Chung S. J. Lee H. I. Moon Antiplasmodial activity of novel stilbene derivatives isolated from Parthenocissus tricuspidata from South Korea Parasitol. Res. 2007 101 237 241
13. W. H. Park S. J. Lee H. I. Moon Antimalarial activity of a new stilbene glycoside from Parthenocissus tricuspidata in mice Antimicrob. Agents Chemother. 2008 52 3451 3453
14. H. W. Lin M. X. Sun Y. H. Wang L. M. Yang Y. R. Yang N. Huang L. J. Xuan Y. M. Xu D. L. Bai Y. T. Zheng K. Xiao Anti-HIV activities of the compounds isolated from Polygonum cuspidatum and Polygonum multiflorum Planta Med. 2010 76 889 892
15. J. F. Dorsey G. D. Kao Aloe(-emodin) for cancer? More than just a comforting salve Cancer Biol. Ther. 2007 6 89 90
16. Q. Huang G. Lu H. M. Shen M. C. Chung C. N. Ong Anti-cancer properties of anthraquinones from rhubarb Med. Res. Rev. 2007 27 609 630
17. H. Z. Lee S. L. Hsu M. C. Liu C. H. Wu Effects and mechanisms of aloe-emodin on cell death in human lung squamous cell carcinoma Eur. J. Pharmacol. 2001 431 287 295
18. Y. Q. Shi T. Fukai H. Sakagami J. Kuroda R. Miyaoka M. Tamura N. Yoshida T. Nomura Cytotoxic and DNA damage-inducing activities of low molecular weight phenols from rhubarb Anticancer Res. 2001 21 2847 2853
19. H. Hibasami K. Takagi T. Ishii M. Tsujikawa N. Imai I. Honda Induction of apoptosis by rhapontin having stilbene moiety, a component of rhubarb (Rheum officinale Baillon) in human stomach cancer KATO III cells Oncol. Rep. 2007 18 347 351
20. X. Shi W. Zhao T. Wang L. Du Y. Wang Z. Zhang S. Wang Effect of rhaponticin on proliferation and differentiation of human hepatoma cell line SMMC-7721 Natl. Med. Front. China 2012 7 11 13
21. S. J. Wakil Fatty acid synthase, a proficient multifunctional enzyme Biochemistry 1989 28 4523 4530
22. F. P. Kuhajda Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology Nutrition 2000 16 202 208
23. H. Liu J. Y. Liu X. Wu J. T. Zhang Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker Int. J. Biochem. Mol. Biol. 2010 1 69 89
24. F. P. Kuhajda Fatty acid synthase and cancer: new application of an old pathway Cancer Res. 2006 66 5977 5980
25. R. Flavin S. Peluso P. L. Nguyen M. Loda Fatty acid synthase as a potential therapeutic target in cancer Future Oncol. 2010 6 551 562
26. J. A. Menendez R. Lupu Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis Nat. Rev. Cancer 2007 7 763 777
27. A. Jayakumar M. H. Tai W. Y. Huang W. al-Feel M. Hsu L. Abu-Elheiga S. S. Chirala S. J. Wakil Human fatty acid synthase: properties and molecular cloning Proc. Natl. Acad. Sci. U. S. A. 1995 92 8695 8699
28. W. X. Tian R. Y. Hsu Y. S. Wang Studies on the reactivity of the essential sulfhydryl groups as a conformational probe for the fatty acid synthetase of chicken liver. Inactivation by 5,5′-dithiobis-(2- nitrobenzoic acid) and intersubunit cross-linking of the inactivated enzyme J. Biol. Chem. 1985 260 11375 11387
29. Y. Y. Lu T. S. Chen J. L. Qu W. L. Pan L. Sun X. B. Wei Dihydroartemisinin (DHA) induces caspase-3-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells J. Biomed. Sci. 2009 16 16
30. J. A. Menendez L. Vellon R. Colomer R. Lupu Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity Int. J. Cancer 2005 115 19 35
31. A. Jemal R. Siegel J. Xu E. Ward Cancer statistics, 2010 Ca-Cancer J. Clin. 2010 60 277 300
32. J. A. Menendez R. Lupu R. Colomer Targeting fatty acid synthase: potential for therapeutic intervention in her-2/neu-overexpressing breast cancer Drug News Perspect. 2005 18 375 385
33. F. P. Kuhajda E. S. Pizer J. N. Li N. S. Mani G. L. Frehywot C. A. Townsend Synthesis and antitumor activity of an inhibitor of fatty acid synthase Proc. Natl. Acad. Sci. U. S. A. 2000 97 3450 3454
34. T. Puig A. Vázquez-Martín J. Relat J. Pétriz J. A. Menéndez R. Porta G. Casals P. F. Marrero D. Haro J. Brunet Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75 Breast Cancer Res. Treat. 2008 109 471 479
35. A. Rashid E. S. Pizer M. Moga L. Z. Milgraum M. Zahurak G. R. Pasternack F. P. Kuhajda S. R. Hamilton Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia Am. J. Pathol. 1997 150 201 208
36. K. Walter S. M. Hong S. Nyhan M. Canto N. Fedarko A. Klein M. Griffith N. Omura S. Medghalchi F. P. Kuhajda M. Goggins Serum fatty acid synthase as a marker of pancreatic neoplasia Cancer Epidemiol., Biomarkers Prev. 2009 18 2380 2385
37. P. L. Alo' P. Visca A. Marci A. Mangoni C. Botti U. Di Tondo Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients Cancer 1996 77 474 482
38. J. V. Swinnen T. Roskams S. Joniau H. Van Poppel R. Oyen L. Baert W. Heyns G. Verhoeven Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer Int. J. Cancer 2002 98 19 22
39. T. S. Gansler W. Hardman 3rd D. A. Hunt S. Schaffel R. A. Hennigar Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival Hum. Pathol. 1997 28 686 692
40. H. Orita J. Coulter E. Tully F. P. Kuhajda E. Gabrielson Inhibiting fatty acid synthase for chemoprevention of chemically induced lung tumors Clin. Cancer Res. 2008 14 2458 2464